Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactions
- 1 July 1993
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 29 (1), S50-S54
- https://doi.org/10.1016/s0190-9622(08)81838-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Hepatic injury associated with itraconazoleThe Lancet, 1992
- Loss of taste and terbinafineThe Lancet, 1992
- Fluconazole-Induced ThrombocytopeniaAnnals of Internal Medicine, 1990
- Initial Experience in Therapy for Progressive Mycoses with Itraconazole, the First Clinically Studied TriazoleClinical Infectious Diseases, 1987
- Hepatic Injury Associated With Ketoconazole TherapyGastroenterology, 1984
- Anaphylactic reactions to ketoconazole.BMJ, 1983
- Is serum gamma-glutamyltransferase a misleading test?BMJ, 1983
- Intrahepatic Cholestasis after Griseofulvin AdministrationGastroenterology, 1976
- Effect of Griseofulvin in Acute Intermittent PorphyriaJAMA, 1964